冠状动脉介入治疗缺血性心肌病顽固性心力衰竭的临床分析

Clinical Analysis of Coronary Intervention in the Treatment of Intractable Heart Failure due to Ischemic Cardiomyopathy

目的分析冠状动脉介入治疗缺血性心肌病顽固性心力衰竭的临床效果。方法选取116例缺血性心肌病顽固性心力衰竭患者。对照组:行常规药物治疗;观察组:行冠状动脉介入手术治疗。结果观察组的治疗有效率是91.38%明显高于对照组的70.69%(P<0.05);观察组患者治疗后的左室射血分数、左室舒张末内径、X线心胸比指标情况要优于对照组(P<0.05)。对照组的不良反应发生率是13.79%,观察组的不良反应发生率是3.44%(P<0.05)。结论冠状动脉介入治疗缺血性心肌病顽固性心力衰竭效果显著,能有效的改善患者的心功能情况,提高生存质量,近期治疗效果较好。

Objective To analyze the clinical effects of percutaneous coronary intervention for treatment of ischemic cardiomyopathy refractory heart failure. Methods 116 cases of ischemic cardiomyopathy patients with refractory heart failure in our hospital were selected and randomly divided into two groups. The control group was treated with routine drug while the observation group was treated with coronary artery interventional therapy. Re-sults The effective rate of the observation group is 91.38% , which was significantly higher than that of the control group （ 70. 69% ） （ P 〈 0. 05 ） . After the treatment, the left ventricular ejection fraction, left ventricular end dias-tolic diameter and the X - ray cardio - thoracic proportion of the observation group were better than those of the con-trol group （ P 〈 0. 05 ） . The adverse reaction rate in the observation group was only 3.44% , prominently lower than that of the control group （13.79% ） （P 〈 0. 05 ） . Conclusion The coronary artery interventional treatment of ischemic cardiomyopathy patients with refractory heart failure shows remarkable therapeutic effectiveness and can ef-fectively improve the heart function and the life quality of patients in the near future.